Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kineta Inc KA

Healthcare Biotechnology
Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance: immunosuppression, exhausted T cells and poor tumor immunogenicity. Its pipeline of immunotherapies includes KVA12123, which is a... see more

Recent & Breaking News (NDAQ:KA)

The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs

Benzinga.com  March 26, 2019

Mid-Afternoon Market Update: DarioHealth Falls Following Q4 Results; Avaya Shares Jump

Benzinga.com  March 25, 2019

Mid-Morning Market Update: Markets Open Lower; Winnebago Industries Posts Mixed Q4 Results

Benzinga.com  March 25, 2019

Proteostasis Therapeutics Announces Broad New Dataset from Proprietary Combination and Add-On CFTR Modulator Studies in Cystic Fibrosis Patients

PR Newswire March 25, 2019

Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors

PR Newswire March 7, 2019

Proteostasis Selected to Join European Consortium to Pioneer Personalized Medicine in Cystic Fibrosis

PR Newswire February 27, 2019

Proteostasis Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference

PR Newswire February 20, 2019

Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors

PR Newswire February 6, 2019

Proteostasis Therapeutics Provides Clinical Enrollment Update

PR Newswire December 20, 2018

Mid-Morning Market Update: Markets Open Lower; Hitachi To Acquire ABB's Power-Grid Unit

Benzinga.com  December 17, 2018

20 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  December 17, 2018

Proteostasis Therapeutics Announces Global License Agreement with Genentech

PR Newswire December 17, 2018

Proteostasis Therapeutics to Participate in Upcoming Investor Conferences

PR Newswire November 21, 2018

Proteostasis Therapeutics Prices Public Offering of Common Stock

PR Newswire October 23, 2018

Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock

PR Newswire October 22, 2018

Thinking about buying stock in Cliffs Natural Resources, eBay, Proteostasis Therapeutics, PayPal Holdings Inc. or Roku Inc.?

PR Newswire October 19, 2018

The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut

Benzinga.com  October 19, 2018

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  October 19, 2018

Mid-Day Market Update: Down Down Over 300 Points; Endocyte Shares Spike Higher

Benzinga.com  October 18, 2018

The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs

Benzinga.com  October 18, 2018